Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis

Beneficial Microbes

Volumn 8, Issue 1, 2017, Pages 65-72

  Levit, R ^a   de Giori, G Savoy ^a,b   de LeBlanc, A de Moreno ^a   LeBlanc, J G ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Inflammatory bowel disease; Lactic acid bacteria; Vitamin production

Indexed keywords

CYTOKINE; PROBIOTIC AGENT; RIBOFLAVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; COLITIS; CONTROLLED STUDY; FEMALE; FERMENTED MILK PRODUCT; HISTOPATHOLOGY; INTESTINE FLORA; INTESTINE FLUID; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; SCORING SYSTEM; SOYBEAN MILK; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; EVALUATION STUDY; FECES; FERMENTATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METABOLISM; PHYSIOLOGY;

ANIMALS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FECES; FEMALE; FERMENTATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS PLANTARUM; MICE; MICE, INBRED BALB C; PROBIOTICS; RIBOFLAVIN; SOY MILK;

EID: 85013192653     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2016.0063     Document Type: Article

References (22)

1. Aghdassi, E., Wendland, B. E., Steinhart, A. H., Wolman, S. L., Jeejeebhoy, K. and Allard, J. P., 2003. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. American Journal of Gastroenterology 98: 348-353
2. Al-Harbi, N. O., Imam, F., Nadeem, A., Al-Harbi, M. M., Iqbal, M. and Ahmad, S. F., 2014. Carbon tetrachloride-induced hepatotoxicity in rat is reversed by treatment with riboflavin. International Immunopharmacology 21: 383-388
3. Alam, M. M., Iqbal, S. and Naseem, I., 2015. Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and DNA damage in type-2 diabetic mice: mechanistic and therapeutic strategies. Archives of Biochemistry and Biophysics 584: 10-19
4. Arena, M. P., Russo, P., Capozzi, V., Rascón, A., Felis, G. E., Spano, G. and Fiocco, D., 2016. Combinations of cereal ß-glucans and probiotics can enhance the anti-inflammatory activity on host cells by a synergistic effect. Journal of Functional Foods 23: 12-23
5. De Moreno de LeBlanc, A., Chaves, S. and Perdigon, G., 2009. Effect of yoghurt on the cytokine profile using a murine model of intestinal inflammation. European Journal of Inflammation 7: 97-109
6. De Moreno de LeBlanc, A. and LeBlanc, J. G., 2014. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World Journal of Gastroenterology 20: 16518-16528
7. Del Carmen, S., De Moreno de LeBlanc, A., Perdigon, G., Bastos Pereira, V., Miyoshi, A., Azevedo, V. and LeBlanc, J. G., 2011. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease. Journal of Molecular Microbiology Biotechnology 21: 138-146
8. Del Carmen, S., Miyoshi, A., Azevedo, V., De Moreno de LeBlanc, A. and LeBlanc, J. G., 2015. Evaluation of a Streptococcus thermophilus strain with innate anti-inflammatory properties as a vehicle for IL-10 cDNA delivery in an acute colitis model. Cytokine 73: 177-183
9. Del Carmen, S., Zurita-Turk, M., Alvarenga Lima, F., Coelho dos Santos, J. S., Leclercq, S. Y., Chatel, J.-M., Azevedo, V., De Moreno de LeBlanc, A., Miyoshi, A. and LeBlanc, J. G., 2013. A novel interleukin-10 DNA mucosal delivery system attenuates intestinal inflammation in a mouse model. European Journal of Inflammation 11: 641-654
10. Hlavaty, T., Krajcovicova, A. and Payer, J., 2015. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? Journal of Crohn's and Colitis 9: 198-209
11. Iwanaga, K., Hasegawa, T., Hultquist, D. E., Harada, H., Yoshikawa, Y., Yanamadala, S., Liao, H., Visovatti, S. H. and Pinsky, D. J., 2007. Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation. Transplantation 83: 747-753
12. Juarez del Valle, M., Laiño, J. E., Savoy de Giori, G. and LeBlanc, J. G., 2014. Riboflavin producing lactic acid bacteria as a biotechnological strategy to obtain bio-enriched soymilk. Food Research International 62: 1015-1019
13. LeBlanc, J. G., Laino, J. E., Juarez del Valle, M., Vannini, V., Van Sinderen, D., Taranto, M. P., Font de Valdez, G., Savoy de Giori, G. and Sesma, F., 2011a. B-group vitamin production by lactic acid bacteria-current knowledge and potential applications. Journal of Applied Microbiology 111: 1297-1309
14. LeBlanc, J. G., Del Carmen, S., Miyoshi, A., Azevedo, V., Sesma, F., Langella, P., Bermudez-Humaran, L. G., Watterlot, L., Perdigon, G. and De Moreno de LeBlanc, A., 2011b. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. Journal of Biotechnology 151: 287-293
15. Mazur-Bialy, A. I., Pochec, E. and Plytycz, B., 2015. Immunomodulatory effect of riboflavin deficiency and enrichment-reversible pathological response versus silencing of inflammatory activation. Journal of Physiology and Pharmacology 66: 793-802
16. Meyer, L., Simian, D., Lubascher, J., Acuna, R., Figueroa, C., Silva, G., Brahm, J. and Quera, R., 2015. Adverse events associated with the treatment of inflammatory bowel disease. Revista Médica de Chile 143: 7-13
17. Moura, F. A., De Andrade, K. Q., Dos Santos, J. C., Araujo, O. R. and Goulart, M. O., 2015. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biology 6: 617-639
18. Powers, H. J., 2003. Riboflavin (vitamin B-2) and health. American Journal of Clinical Nutrition 77: 1352-1360
19. Roggenbuck, C., Lammert, F., Berthold, H. K., Giese, T., Stallmach, A., Stehle, P. and Ellinger, S., 2008. High-dose oral supplementation of antioxidants and glutamine improves the antioxidant status in patients with Crohn's disease: a pilot study. European Journal of Clinical Nutrition and Metabolism 3: e246-e253
20. Russo, P., Capozzi, V., Arena, M. P., Spadaccino, G., Duenas, M. T., Lopez, P., Fiocco, D. and Spano, G., 2014. Riboflavin-overproducing strains of Lactobacillus fermentum for riboflavin-enriched bread. Applied Microbiology and Biotechnology 98: 3691-3700
21. Russo, P., De Chiara, M. L. V., Capozzi, V., Arena, M. P., Amodio, M. L., Rascón, A., Dueñas, M. T., López, P. and Spano, G., 2016. Lactobacillus plantarum strains for multifunctional oat-based foods. LWT-Food Science and Technology 68: 288-294
22. Thakur, K., Tomar, S. K. and De, S., 2015. Lactic acid bacteria as a cell factory for riboflavin production. Microbial Biotechnology 9: 441-451